The use of fospropofol during bronchoscopy.

  title={The use of fospropofol during bronchoscopy.},
  author={J. Thomas McLarney and Kevin W. Hatton and Matthew J Swan},
  volume={136 3},
The author has reported to the ACCP that no significant conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article. © 2009 American College of Chest Physicians. Reproduction of this article is prohibited without written permission from the American College of Chest Physicians ( misc/reprints.xhtml). Correspondence to: Almerico Marruchella, MD, FCCP, Istituto Nazionale per le Malattie Infettive, Respiratory… Expand
Titrated Sedation with Propofol for Medical Thoracoscopy: A Feasibility and Safety Study
BIS-guided propofol sedation is a safe method that might replace midazolam sedation in MT and can be managed by well-trained nonanesthesiologist personnel. Expand
Fospropofol, a new sedative anesthetic, and its utility in the perioperative period.
Fospropofol is an intravenous sedative-anesthetic agent that is FDA-approved for monitored anesthesia care (MAC) sedation in adult patients undergoing diagnostic or therapeutic procedures and is successful in patients undergoing esophagogastroscopy, colonoscopy and flexible bronchoscopy. Expand
Bolus-Dose Fospropofol Disodium (Lusedra ® ): Is 10 mg/Kg Superior To 6.5 mg/Kg for Sedation in Patients Undergoing Regional Anesthesia Blocks Prior to Orthopedic Surgery?
10 mg/kg bolus-dose fospropofol was 100% successful in producing sedation in less than 4 minutes, but was accompanied by deep sedation (p+0.048) and delayed recovery from sedation and more frequent apnea that make this dose unsuitable for procedures requiring short or minimal-to-moderate sedation. Expand


The old and the new of sedation for bronchoscopy.
Life threatening unilateral pulmonary overinflation might be more successfullytreated by contralateral selective intubation than by emergency pneumonectomy by using non-invasive strategies for the management of suspected ventilator-associated pneumonia. Expand
Risk of malignant neoplasms in patients with pulmonary sarcoidosis.
This study does not support the theory of an association between sarcoidosis and malignancy, and the main reason other studies have shown such an association is most likely to have been due to selection bias and misclassification. Expand
A 49-year-old man with concurrent diagnoses of lung cancer, sarcoidosis, and multiple regions of adenopathy on positron emission tomography.
A 49-year-old, white man with a 100–pack-year smoking history presented with progressive scapular paresthesias and pain radiating down his right arm for 6 weeks, significant for low-grade transitional cell bladder cancer status post transurethral bladder resection. Expand
Sarcoidosis and malignancy.
Malignancy can be associated with the occurrence of sarcoid reactions that typically are restricted to the regional lymph nodes or the visceral organ of tumor origin; rarely, the Sarcoid reaction can also be observed in the skin or is only limited to the skin. Expand
ACCP that no significant conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article
  • American College of Chest Physicians. Reproduction
  • 2009
woman with a history of breast cancer
  • Chest
  • 2007
Sarcoid and malignant neoplasm: the Mayo Clinic experience
  • Sarcoidosis
  • 1986